Lidings’ Corporate and M&A practice team has successfully concluded its advisory role for the owners of Autotechinmash LLC, the largest auto dealer of Belarusian cars, in restructuring of the company’s founding team.

Russia and the Gulf countries continue to deepen economic cooperation, which becomes especially important against the backdrop of sanctions restrictions. The Russian-Gulf Business Forum: New Ties, New Opportunities (took place in Moscow on 24 September 2024) provided an opportunity for a comprehensive discussion of both business prospects and legal issues related to the activities of Russian companies in the region.

Highlights of the event in our report.

Lidings has signed a cooperation agreement with Leadvisor Global, an international network of consultants. The firm has become the first national legal counsel to represent Russia.

We are delighted to announce that Lidings has updated The Pharma Legal Handbook: Russia - practical directory focused on the key aspects of legislative regulation of pharmaceutical industry in Russia.

On May 14, in Moscow, Lidings held PHARMAtory - a traditional event for representatives of the pharmaceutical industry, where we discuss the most topical issues of the industry. This year the meeting took place during the Semashko Russian Pharmaceutical Forum in St. Petersburg (May 14 - 15).

Saint Petersburg will yet again host Semashko Russian Pharmaceutical Forum, a major event covering key aspects of the Russian pharmaceutical regulation. As a long-standing tradition, Lidings takes part in the Forum and supports the event as a partner.  This year, Lidings supports the online broadcast of this large-scale event.

Lidings takes high positions in the new rating of the leading legal advisors in Russia based on the analytical research held annually by the “Kommersant” newspaper. In 2024 the firm is ranked among the TOP leading legal advisors in Russia. 

On April 11, 2024, in Moscow, the annual Pravo.ru conference "Pharmaceuticals – 2024: Legal Issues" will take place. Lidings lawyers traditionally take an active part in the event’s program.

As a strategic partner of the conference, we have endeavored to make the program as comprehensive and useful as possible. Together with experts from the pharmaceutical industry and legal experts, we will discuss current issues in industry regulation, legislative changes, market access, government procurement, and distribution. We will also touch upon marketing and promotion issues, as well as discuss strategies for protecting intellectual property.

Lidings' sanctions compliance and corporate & M&A practice lawyers managed the conversion of depositary receipts (ADRs) into stocks of a Russian issuer in support of private clients from Europe and the United States.